Elanco Animal Health IncNYSE:ELAN
- LAST PRICE14.1300
- TODAY'S CHANGE (%)0.1200 (0.8565%)
- Bid / Lots13.9100/ 1
- Ask / Lots14.5200/ 1
- Open / Previous Close14.3200 / 14.0100
- Day Range
- 52 Week Range
- Volume2,717,228
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ELAN |
|---|---|---|
| 09:32 ET | 44745 | 14.19 |
| 09:34 ET | 2241 | 14.295 |
| 09:36 ET | 2500 | 14.275 |
| 09:38 ET | 5069 | 14.37 |
| 09:39 ET | 8116 | 14.34 |
| 09:41 ET | 10666 | 14.33 |
| 09:43 ET | 13415 | 14.325 |
| 09:45 ET | 3477 | 14.375 |
| 09:48 ET | 1647 | 14.37 |
| 09:50 ET | 16815 | 14.35 |
| 09:52 ET | 3610 | 14.35 |
| 09:54 ET | 10866 | 14.29 |
| 09:56 ET | 19322 | 14.32 |
| 09:57 ET | 2489 | 14.32 |
| 09:59 ET | 8121 | 14.315 |
| 10:01 ET | 38695 | 14.415 |
| 10:03 ET | 28422 | 14.385 |
| 10:06 ET | 20253 | 14.375 |
| 10:08 ET | 25936 | 14.405 |
| 10:10 ET | 24919 | 14.425 |
| 10:12 ET | 23726 | 14.435 |
| 10:14 ET | 40848 | 14.435 |
| 10:15 ET | 44617 | 14.4202 |
| 10:17 ET | 20749 | 14.37 |
| 10:19 ET | 38579 | 14.26 |
| 10:21 ET | 42661 | 14.255 |
| 10:24 ET | 18493 | 14.24 |
| 10:26 ET | 21147 | 14.27 |
| 10:28 ET | 9772 | 14.2497 |
| 10:30 ET | 8502 | 14.23 |
| 10:32 ET | 16727 | 14.231 |
| 10:33 ET | 2352 | 14.23 |
| 10:35 ET | 20103 | 14.2099 |
| 10:37 ET | 5513 | 14.215 |
| 10:39 ET | 14321 | 14.205 |
| 10:42 ET | 10553 | 14.175 |
| 10:44 ET | 8821 | 14.135 |
| 10:46 ET | 9524 | 14.1488 |
| 10:48 ET | 10161 | 14.15 |
| 10:50 ET | 4631 | 14.155 |
| 10:51 ET | 2765 | 14.16 |
| 10:53 ET | 14465 | 14.1499 |
| 10:55 ET | 13121 | 14.17 |
| 10:57 ET | 60680 | 14.155 |
| 11:00 ET | 29201 | 14.17 |
| 11:02 ET | 9515 | 14.175 |
| 11:04 ET | 32426 | 14.17 |
| 11:06 ET | 2975 | 14.175 |
| 11:08 ET | 13354 | 14.14 |
| 11:09 ET | 8700 | 14.15 |
| 11:11 ET | 2475 | 14.155 |
| 11:13 ET | 14032 | 14.15 |
| 11:15 ET | 17848 | 14.165 |
| 11:18 ET | 3964 | 14.165 |
| 11:20 ET | 26701 | 14.15 |
| 11:22 ET | 50918 | 14.18 |
| 11:24 ET | 23672 | 14.185 |
| 11:26 ET | 8926 | 14.165 |
| 11:27 ET | 17711 | 14.195 |
| 11:29 ET | 8233 | 14.18 |
| 11:31 ET | 2405 | 14.18 |
| 11:33 ET | 18172 | 14.185 |
| 11:36 ET | 18800 | 14.22 |
| 11:38 ET | 59144 | 14.215 |
| 11:40 ET | 45566 | 14.225 |
| 11:42 ET | 25683 | 14.235 |
| 11:44 ET | 46835 | 14.26 |
| 11:45 ET | 32112 | 14.235 |
| 11:47 ET | 51771 | 14.215 |
| 11:49 ET | 14825 | 14.175 |
| 11:51 ET | 3046 | 14.185 |
| 11:54 ET | 14270 | 14.18 |
| 11:56 ET | 16937 | 14.16 |
| 11:58 ET | 561 | 14.16 |
| 12:00 ET | 2658 | 14.1699 |
| 12:02 ET | 3811 | 14.17 |
| 12:03 ET | 15060 | 14.165 |
| 12:05 ET | 31376 | 14.14 |
| 12:07 ET | 1286 | 14.145 |
| 12:09 ET | 22053 | 14.2 |
| 12:12 ET | 18191 | 14.19 |
| 12:14 ET | 20897 | 14.195 |
| 12:16 ET | 9853 | 14.165 |
| 12:18 ET | 10816 | 14.16 |
| 12:20 ET | 8570 | 14.155 |
| 12:21 ET | 10364 | 14.155 |
| 12:23 ET | 33110 | 14.175 |
| 12:25 ET | 3133 | 14.185 |
| 12:27 ET | 5470 | 14.18 |
| 12:30 ET | 14345 | 14.16 |
| 12:32 ET | 3349 | 14.16 |
| 12:34 ET | 6441 | 14.165 |
| 12:36 ET | 16159 | 14.17 |
| 12:38 ET | 22097 | 14.16 |
| 12:39 ET | 14348 | 14.18 |
| 12:41 ET | 24912 | 14.17 |
| 12:43 ET | 3957 | 14.18 |
| 12:45 ET | 23734 | 14.16 |
| 12:48 ET | 120312 | 14.18 |
| 12:50 ET | 11612 | 14.185 |
| 12:52 ET | 42688 | 14.175 |
| 12:54 ET | 78979 | 14.205 |
| 12:56 ET | 45063 | 14.2 |
| 12:57 ET | 73513 | 14.17 |
| 12:59 ET | 368520 | 14.13 |
Yesterday
ELAN Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Elanco Animal Health Incorporated (NYSE: ELAN) Investors with Significant Losses to Contact the Firm, from 11 hours ago by Dow Jones
11 hours ago by Dow JonesAn Investigation Has Commenced on Behalf of Elanco Animal Health Incorporated Shareholders. Contact Levi & Korsinsky to Discuss your ELAN Losses., from 12 hours ago by Dow Jones
12 hours ago by Dow JonesELAN INVESTIGATION REMINDER: Elanco (NYSE:ELAN) Investors that Suffered Losses are Encouraged to Contact BFA Law about Securities Fraud Investigation, from 12 hours ago by Dow Jones
12 hours ago by Dow JonesELAN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Inquiry into Elanco Animal Health Incorporated and Urges Stockholders to Contact the Firm!, from 17 hours ago by Dow Jones
17 hours ago by Dow JonesElanco Animal Health Incorporated INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Elanco (ELAN), from 20 hours ago by Dow Jones
20 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Elanco Animal Health Inc | 6.9B | -5.3x | --- |
PetIQ Inc | 672.1M | 104.8x | --- |
Phibro Animal Health Corp | 676.4M | 52.8x | -13.61% |
Supernus Pharmaceuticals Inc | 1.4B | -91.5x | -59.02% |
Eagle Pharmaceuticals Inc | 67.9M | 6.0x | -4.75% |
Shengtai Pharmaceutical Inc | 10.0 | 0.0x | --- |
Company Information
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, poultry, and aquaculture. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Contact Information
- Headquarters
- 2500 Innovation Way NGREENFIELD, IN, United States 46140-9163
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Lawrence Kurzius
- President, Chief Executive Officer, Director
- Jeffrey Simmons
- Chief Financial Officer, Executive Vice President
- Todd Young
- Executive Vice President, General Counsel, Company Secretary
- Shiv O'Neill
- Executive Vice President, Human Resources, Corporate Communications and Administration
- David Kinard
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.0B |
|---|---|
Revenue (TTM) | $4.4B |
Shares Outstanding | 494.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.42 |
EPS | $-2.64 |
Book Value | $12.63 |
P/E Ratio | -5.3x |
Price/Sales (TTM) | 1.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -21.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
